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Abstract
Bivalent and trivalent cations quelate oxytetracyline (OTC), rendering it microbiologically inac-
tive. Yet shrimp diseases are often treated with OTC in pelleted feeds. Attempts have been
made to chemically protect the OTC concentration in shrimp feeds against degradation in brack-
ish water and due to temperature. The antibacterial activity of two such environmentally-protect-
ed OTC preparations (premixes A and B) and one unprotected OTC premix (C) were tested (a)
before and after pelleting the OTC premixes with the powdered feed ingredients and (b) during
decay-dispersion of the OTC-medicated feed in brackish water. In all three treatments, the OTC
concentration dropped by approximately half after pelleting (p<0.001). When pellets were placed
in tanks containing water of 23-25°C, pH 7.6-7.8, and marine salt (40 g/l), a second order expo-
nential decay of antibacterial activity followed, reaching 50% in 30 min. At 150 min, loss reached
80% in group A, 85% in group B, and 98% in group C, suggesting that only environmentally-pro-
tected OTC may, in some cases, reach the minimal therapeutic concentration necessary to treat
Vibrio spp. diseases.
Introduction 
The modern shrimp industry requires antibac-
terials to limit or prevent the outbreak and
spread of bacterial diseases caused mainly by
Vibrio and Rickettsia spp. (Lightner, 1993). In
spite of being highly quelated by bi and triva-
lent cations such as Ca++ and Mg++ that are
abundant in marine waters and pond sedi-
ments, the perhaps most widely used antibac-
terial drug is oxytetracycline (OTC), one of the
few antibacterial agents approved for shrimp
*  Corresponding author. Tel./fax: +52-55-5622-5980, e-mail: sumano@servidor.unam.mx
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by the U.S. Food and Drugs Administration
(http://www.fda.gov/cvm/drugsuseaqua.htm).
Usually, OTC is added to pelleted feed as an
ingredient or an external layer in concentra-
tions that fluctuate 100-5000 mg/kg (Corliss et
al., 1977; Wang et al., 2003). 
While reasonable to assume that shrimp
feeding on the treated pellets will receive an
appropriate amount of OTC, to the best of our
knowledge this assumption has not been
proven. Shrimp eating habits do not comply
with a linear approach. Species do not feed
while molting (Hill and Wassenberg, 1992) or
undergoing a disease (Lightner, 1993) and
food intake may change when OTC is added to
the feed. Further, OTC is degraded by sunlight,
heat, and changes in pH, salinity, or pressure
(Lunestad et al. 1995; Doi and Stoskopf, 2000),
conditions to which pelleted shrimp feed is sub-
jected during processing and before it reaches
the stomach and gastrointestinal tract of the
shrimp. It is therefore reasonable to question
what fraction of the dose reaches the target
species. Some pharmaceutical manufacturers
incorporate polymer-covered OTC into feed-
pellets to protect it from environmental influ-
ences. Neverthe-less, the efficacy of this prac-
tice remains to be evaluated.
The goal of this study was to assess the
degree of OTC degradation during food pro-
cessing and the influence of marine water on
the decay-degradation of its antibacterial
potency. These factors were compared in two
environmentally-protected OTC premixes and
one unprotected premix.
Materials and Methods
Feeds. Commercial 20% oxytetracycline hydro-
chloride (OTC) premixes, obtained from retail-
ers, were added to antibacterial-free feed
ingredients at a rate of 2000 µg/g (Table 1).
Two of the premixes, Capsotetra® (Avimex,
Mexico; A) and Ascotetra® (Avimex, Mexico;
B), were polymer-covered and supposedly
environmentally protected. The third premix,
Terramix® (Pfizer, Mexico; C), was not pro-
tected. The powdered feed was pelleted at 82-
145°C and a pressure of 620-740 psi (Cruz-
Suarez et al., 2001) using Maxi-Bond® as a
binder. Six batches of each premix were
obtained from the retailers, used to prepare a
batch of feed, and kept sealed under refriger-
ation for no more than seven days before
antibacterial potency was determined. 
Antibacterial potency. The antibacterial
potency of the OTC was tested before and
after mixing it into the powdered feed and
after pelleting the mixtures. Potency was
determined in six replicates per batch (i.e.,
324 analyses).
Decay-dispersion. To assess the influence
of salinity on OTC degradation, 40 g/l
Coralife® Salt (Energy Savers Unlimited) was
used to mimic brackish water in standard
Mexican ponds. Temperature was kept at 23-
25°C with a thermostat (LED 200 Watts
Dymax), pH was approximately 7.6-7.8
(Conductronic pH20), and aeration was con-
tinuously provided at 6.79-6.56 mg/l. The pel-
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Ingredient %
Fish meal 34.8
Soybean oil cake 30.0
Wheat meal 30.2
Shrimp meal 0.8
Fish oil 1.17
Lecithin 0.5
Vitamin mix1 0.5
Vitamin C-StayC® 0.05
Lysine 0.5
Methionine 0.5
Binder2 0.8
Table 1. Composition of the diet as pro-
posed by Tacon (1987ab).
1 Vitamin mixture: 4,000 IU/g vitamin A;
24,000 mg/kg B1; 16,000 mg/kg B2; 30,000
mg/kg calcium d-pantothenate; 30,000
mg/kg B6; 80 mg/kg B12; 60,000 mg/kg C;
16,000 mg/kg K3; 3,200 IU/g D3; 60,000
mg/kg E; 400 mg/kg H; 20,000 mg/kg
niacin; 4,000 mg/kg folic acid
2 Maxi-Bond® (urea formaldehyde/calcium
sulfate)
leted feeds (six replicates per batch of premix)
were placed in 40-l glass containers and left to
interact with the water for 2.5 h. Samples of
sedimented pellets (5 g) were taken from
each water container after 1, 5, 30, 60, 90,
120, and 150 min (an additional 756 analy-
ses). Samples were dried at 25°C for 8 h, then
placed in a vacuum dryer for 3 h, and kept in
air-tight containers at -20°C until analyzed.
Extraction of oxytetracycline. OTC was
extracted as described by Martinez and
Shimoda (1988) as follows. Samples were
thawed at room temperature, 5 g were sepa-
rated, vortexed for 20 min with 25 ml of
McBuffer A (614.5 ml 0.10 M citric acid, 385.5
ml 0.20 M disodium hydrogen phosphate, and
0.372 g Na2EDTA to pH 2), then centrifuged
for 15 min at 4000 x g. The supernatant was
collected and the sediment extracted with 25
ml of McBuffer B (614.5 ml 0.10 M citric acid,
385.5 ml 0.20 M disodium hydrogen phos-
phate, and 37.2 g Na2EDTA to pH 4.5). The
two pooled samples of supernatant extrac-
tions were put into an Erlenmeyer flask, nitro-
gen was injected with a pointed tube, and the
extractions were dried in a water bath for
approximately 45 min. The resulting powder
was resuspended in 50 ml of de-ionized ster-
ile water and centrifuged for 15 min at 2500 x
g to obtain a clear supernatant that was fil-
tered through Millipore nylon membranes
(0.45 µm). Antibacterial activity, expressed as
OTC concentration, was assessed in 100-µl
samples of the supernatant.
Oxytetracycline concentration. OTC con-
centrations were determined by modified agar
diffusion analysis as described by Bennett et
al. (1966) with Bacillus cereus (ATCC 11778)
grown on Mueller-Hinton agar (Bioxon®) as
the test organism. Drug concentrations were
determined using linear regression analysis to
compare diameters of zones of inhibition with
those of various dilutions of the standard pre-
pared in distilled sterile water. The intra-assay
coefficient of variance was <4.6 and inter-
assay error <4.9. The analytical assay was lin-
ear over a range of concentrations of 0.391-
500 µg/ml with a recovery of 99.64±0.569% (n
= 16) and a correlation coefficient of
0.995±2.1. 
Statistical analysis. Data regarding the
effects of pelleting were entered into an SAS-
statistical package (SAS System V. 8.8 2004,
Institute Inc.) and mean differences in
antibacterial activity, expressed as OTC con-
centration, were compared using ANOVA.
Losses of antibacterial activity with time
(decay-dispersion), again expressed as OTC
concentration, were compared by repeated
measurements using mixed model analysis
through ANOVA.
Results
OTC contents in premixes and powdered feed
before pelleting did not significantly differ
(p<0.001) between treatments (Table 2).
However, after pelleting, the content in C was
significantly lower than in B (p = 0.0086), i.e.,
11.01% lower and 48.9% less than expected.
After exposure to 2.5 h in water, pellets
underwent a sharp, constant, and well-defined
drop in antibacterial activity (Table 3). At 30
min, more than half the concentration had
been lost in all treatments. Later, the slopes of
premixes A and B differed from the slope of
premix C (Fig. 1) although regression analysis
in all three cases best fitted second order
exponential curves (r2>0.99 in all cases). After
150 min, OTC concentrations in pellets pre-
pared with premixes A and B were statistical-
ly higher than in pellets prepared with premix
C (p<0.001). Nevertheless, the OTC loss in all
groups was considerable, reaching final loss-
es of 80% in group A, 85% in group B, and
98% loss in group C.
Discussion
Before pelleting, OTC concentrations in the
powdered feed did not differ between treat-
ments. However, the process of pelleting
reduced antibacterial activity, expressed as
OTC concentration, by almost half (44% in A,
38% in B, and 49% in C). The statistically sig-
nificant difference between groups B and C
suggests that the environmental protection
actually reduced degradation of the active
principle. However, almost 1000 µg/g of OTC
were lost during pellet processing; therefore,
further work is needed to obtain efficient pro-
tection. 
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Because OTC is highly chelated by calci-
um and magnesium ions, our findings could
have been predicted and agree with those of
Lunestad and Goksoyr (1990) and Doi and
Stoskopf (2000) who showed that OTC is
more prone to be chelated with bi and trivalent
cations when subjected to environmental fac-
tors such as high temperature (>43°C), high
salinity, alkaline pH, or lamp light (Lunestad et
al., 1995). In particular, Mohney et al. (1997)
highlighted temperature as the most degrad-
ing factor; standard pelleting usually requires
temperatures above 60°C.
In our study, OTC losses due to pelleting
were much more pronounced than reported
by Frelier (1995) who obtained losses ranging
10-40%. Using unprotected OTC in extruded
pellets, Fernandez-Gonzalez et al. (2002)
obtained a 30% loss of concentration, lower
than values obtained in our study even in the
environmentally-protected treatments (38-
49%). Hence, the polymer-protective outer-
most layer of the OTC particles in premixes A
and B can be regarded as having little effec-
tiveness in preventing degradation when feed
is pelleted, although differences among
authors can be attributed to analytical meth-
ods used in each case.
A well-defined decay-dispersion process,
with a second order exponential OTC decay,
was obtained in all three treatments. Although
slight protection was obtained with premixes
A and B, OTC concentrations in treatments A
and B after 150 min reveal a protective effect
of only 15-20% compared to the unprotected
treatment C. The resulting loss of OTC con-
centration means that shrimp in group A that
ingest softened pellets from the bottom of a
pond after 150 min will receive a dose of 400
µg OTC/g feed rather than 2000 µg/g, as
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Fig. 1. Decay-dispersion of oxytetracycline (OTC) in brackish water, presented
as second order exponential decay (r>0.99) of antibacterial activity (expressed as
concentration) in pelleted shrimp feeds prepared with environmentally-protected
oxytetracycline premix A or B or unprotected premix C.
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expected. Disregarding palatability, a 7-g
shrimp in optimum conditions may have a
daily food ingestion equivalent to 4.4% of its
body weight (Jory, 1995). Such a shrimp
would consume 123.2 µg OTC per day, equiv-
alent to 17.6 mg/kg body mass, probably
enough to cover but not surpass the minimum
inhibitory concentration (MIC) for most Vibrio
spp. microorganisms (0.1-12.5 µg/ml; Taka-
hashi et al., 1985). The OTC concentration in
unprotected treatment C was noticeably lower
and the final dose for a 7-g shrimp ingesting
softened pellets after 150 min would be only
11.6 µg OTC per day, equivalent to 1.7 mg/kg
biomass. More importantly, the food ingestion
of shrimp infected by Vibrio drops to only 0-
1% their body weight (Lightner, 1993). In such
a case, the total OTC dose of a 7-g shrimp
consuming environmentally-protected OTC
would be only 4 mg/kg body mass which is
unlikely to meet the required MIC. The above
assumptions need revision as Penaeus spp.
have varying eating habits (Sedgwick, 1979;
Nunes and Parsons, 2000). 
Early detection of Vibrio infection requires a
relatively simple laboratory procedure (Lightner,
1993). At early stages of infection, food con-
sumption is not drastically hampered. Therefore
medication with OTC is possible, but only if
environmentally-protected OTC is used to man-
ufacture feed pellets. Better protection of this
drug should be sought because a slight reduc-
tion in feed consumption or more rapid decay
and dispersion may result in inadequate levels
of OTC in these animals. This is a pharmaceuti-
cal task that should take into account not only
the stability of OTC but also the palatability of
the outermost layer of the OTC particles.
In short, standard pellet processing of
shrimp feeds containing OTC premixes
reduces the antibacterial activity of this drug
by approximately half, whether the premix is
environmentally-protected or not. Further and
rapid decrease in antibacterial activity occurs
when OTC-containing feed pellets are placed
in brackish water. The loss of antibacterial
activity of environmentally-protected OTC
occurs at a slightly slower rate than of non-
protected OTC. This difference may be impor-
tant when treating diseased Penaeus,
depending on the progress of the disease and
the eating habits of the species.
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